SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001199835-23-000025
Filing Date
2023-01-20
Accepted
2023-01-20 16:51:12
Documents
14
Period of Report
2023-01-11
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 8-K form_8k.htm   iXBRL 8-K 25796
2 LETTER FROM FRIEDMAN LLP TO THE SECURITIES AND EXCHANGE COMMISSION DATED JANUARY ex_16-1.htm EX-16.1 2956
3 GRAPHIC friedmanllp_logo.jpg GRAPHIC 8734
  Complete submission text file 0001199835-23-000025.txt   213876

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pkph-20230111.xsd EX-101.SCH 3203
5 XBRL LABEL FILE pkph-20230111_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE pkph-20230111_pre.xml EX-101.PRE 22773
8 EXTRACTED XBRL INSTANCE DOCUMENT form_8k_htm.xml XML 3448
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

IRS No.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-53855 | Film No.: 23541605
SIC: 2834 Pharmaceutical Preparations